Calquence 100 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FXAER
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,563
Award facts
- Contract value 100% obligated
- $33,562.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-count units) with a contract value of $33,562.68. This firm fixed-price delivery order, awarded on September 17, 2025, with an ultimate completion date of October 8, 2025, represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its Corporate Office location. The delivery order is structured as a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
This delivery order exemplifies AmerisourceBergen's critical role as a pharmaceutical supplier within the Defense Logistics Agency's Medical Supply Chain, which procures essential medications and medical supplies for military and veteran healthcare systems. Calquence, a targeted therapy used in treating certain hematologic malignancies, aligns with the company's extensive portfolio of specialty pharmaceuticals and brand-name medications supplied to federal healthcare customers including the Defense Health Agency and U.S. Coast Guard. The firm fixed-price structure and rapid completion timeline reflect the operational efficiency of the DLA Pharmaceutical Prime Vendor program in delivering time-sensitive medical commodities to support military healthcare readiness worldwide.
Quick answers
Who was awarded contract SPE2DB25FXAER?
SPE2DB25FXAER was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FXAER worth?
The government has obligated $33,563 on SPE2DB25FXAER.
Is contract SPE2DB25FXAER an order under another contract?
Yes. SPE2DB25FXAER is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FXAER competed?
The extent of competition for SPE2DB25FXAER was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award